Get the Weekly Intelligence Brief — top committee picks every Sunday.
SBRA · NASDAQ · STOCK

Sabra Health Care REIT (SBRA) Stock Analysis

Real Estate Updated October 10, 2026
$18.97
52W $17.17 – $22.77
58/100
$4.78B
71.8
0.62
AI Committee Verdict
Watch
58/100
Conviction: Contested · 50% agreement · 6 analysts
+0.1%
-5.9%
0.01:1
Contested

Is SBRA Bullish or Bearish?

Mixed. Innellis AI committee rates Sabra Health Care REIT (SBRA) Watch with a composite score of 58/100 , based on 6 analysts with 50% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +1.88 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -18.12 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+1.00 across 1 articles, 14d). Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Dividend yield of 8.3% pays you to wait — Value
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
  • News sentiment is positive (+1.00 across 1 articles, 14d) — News
Bear Case
  • P/E of 74.0 is expensive by classic value standards — Value
  • ROE of only 2.3% -- cheap may mean cheap for a reason — Value
  • EPS declining -65.8% YoY despite any revenue growth — Growth
  • 4 consecutive earnings misses -- execution concerns — Growth
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
58/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 20%
of 80 Real Estate peers
Value Analyst bearish
35 / 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
+ Dividend yield of 8.3% pays you to wait
− P/E of 74.0 is expensive by classic value standards
Growth Analyst bearish
35 / 100 · High confidence
Growth story is weak, decelerating, or inconsistent
− EPS declining -65.8% YoY despite any revenue growth
Technical Analyst neutral
54 / 100 · High confidence
Mixed or range-bound price action
+ Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement
− MACD histogram negative -- bearish momentum
Risk Analyst bullish
70 / 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
90 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+1.00 across 1 articles, 14d)
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 56.9 to 58.1.

Analyst-level changes:
  • Technical Analyst: score 46->54 (+8).
  • Value Analyst: +1 bearish signal(s).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
30.3
Neutral
MACD Histogram
-0.070
Bearish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Mixed
Support
$17.86
Resistance
$18.98
Bollinger %B
0.18
Inside Bands
Price vs Moving Averages
EMA 9
$19.16 Below
EMA 21
$19.57 Below
EMA 50
$19.97 Below
EMA 200
$19.81 Below

Fundamental Analysis

Valuation
65
Growth
10
Profitability
48
Financial Health
88
Cash Flow
70
Valuation
P/E Ratio 71.8×
P/B Ratio 1.74×
PEG Ratio -1.08
Dividend Yield 6.33%
52W High $22.77
52W Low $17.17
Quality & Growth
ROE 551.5%
ROA 283.3%
Gross Margin 6184.3%
Operating Margin 1530.6%
Revenue Growth YoY —
Debt / Equity 0.96
AI Fundamental Assessment
P/E ratio of 71.8 (rich relative to a 15-40x range); Price-to-book of 1.7x; PEG ratio of -1.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 5.5%; Return on assets of 2.8%; Net margin of 7.6%; Gross margin of 61.8%; Current ratio of 43.68 (healthy short-term liquidity); Debt-to-equity of 0.96; Free cash flow per share is positive (1.37); Most recent quarter missed estimates by 156.7%; 4 consecutive earnings misses; EPS growth decelerating (+45.5% -> -162.5% QoQ); Average YoY EPS growth of -137.0%; Analyst estimates flat over recent quarters
Get the Full SBRA Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime